분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2015-07-28 19:24:54 , Hit : 917
 FDA approves hepatitis C drugs from AbbVie, Bristol-Myers

Thomson Reuters  
Edition:
U.S.

Health  |  Fri Jul 24, 2015 5:43pm EDT
Related:  Health  

AbbVie, Bristol-Myers get FDA nod for hep C treatments

The U.S. Food and Drug Administration on Friday approved two treatments for less common forms of hepatitis C virus (HCV) infections.

The regulator cleared AbbVie Inc's Technivie, which targets HCV genotype 4 infections, and Bristol-Myers Squibb Co's Daklinza, used to treat HCV genotype 3 infections.

About 2.7 million Americans are infected with HCV, of which 10 percent are genotype 3. Genotype 4 is considered among the least common, according to the Centers for Disease Control and Prevention.

Both treatments do not require the co-administration of older antivirals, the regulator said.

The viral disease causes inflammation of the liver that can lead to diminished function or failure of the organ.

Technivie comprises three drugs that are included in Viekira Pak, AbbVie's regimen for the most common form of HCV infection - genotype 1. (1.usa.gov/1gSuFvU)

Technivie is the first regimen approved to safely and effectively treat genotype 4, while Daklinza is the first for genotype 3, the FDA said.

The regulator has approved the use of Daklinza in combination with Gilead Sciences Inc's Sovaldi. (1.usa.gov/1VFlkaX)

Viekira Pak raked in sales of $231 million in the first quarter 2015, while Gilead's Sovaldi brought in $972 million in the same period.

(The story corrects paragraph six to say Technivie "comprises three drugs that are included in Viekira Pak", not "includes the same cocktail of drugs that comprise Viekira Pak")


(Reporting by Samantha Kareen Nair in Bengaluru; Editing by Kirti Pandey and Saumyadeb Chakrabarty)







907    [바이오토픽] 2015 노벨화학상: 세포의 비밀을 밝혀낸 화학자들  이성욱 2015/10/08 1890
906   바이오통신원 [바이오토픽] 2015 노벨생리학상을 휩쓴 기생충약 개발자들  이성욱 2015/10/06 1779
905   노벨 생리의학상 유감(有感)  이성욱 2015/10/06 812
904   혁신적인 폐암 면역치료제를 승인한 FDA  이성욱 2015/10/06 990
903   지방간과 흉터가 유전과 관련되어 있다?  이성욱 2015/10/05 1018
902   바이러스가 살아있다는 증거를 더한 연구  이성욱 2015/10/05 947
901   화성의 물에서 생명체를 찾는 것의 어려움  이성욱 2015/10/01 981
900   CRISPR/Cas9의 대안: CRISPR/Cpf1  이성욱 2015/09/29 1414
899   UPDATE 2-Gilead experimental drug fights all forms of hep C: data  이성욱 2015/09/24 829
898   RNA-Based Therapeutics and Vaccines  이성욱 2015/09/21 1023
897   힝스턴 그룹, 인간배아 유전자 편집의 윤리적 정당성 인정  이성욱 2015/09/16 1171
896   혈액 암과 면역세포의 DNA 편집의 관계  이성욱 2015/09/14 985
895   아스피린이 암의 면역요법 효과 증대  이성욱 2015/09/08 873
894   처음으로 밝혀진 수면부족과 감기 간의 관련성  이성욱 2015/09/03 902
893   알츠하이머 질환에 대한 항체약물의 가능성  이성욱 2015/07/30 1048
892   DNA 앰블런스  이성욱 2015/07/30 995
891   유전자 넉아웃을 보상하는 또 다른 유전자  이성욱 2015/07/30 1229
  FDA approves hepatitis C drugs from AbbVie, Bristol-Myers  이성욱 2015/07/28 917
889   항-PD-1 항체에 저항성을 보이는 기작  이성욱 2015/07/28 1116
888   항체 함암제를 테스트할 수 있는 인간화 생쥐 모델  이성욱 2015/07/28 1359

[이전 10개] [1]..[11][12][13][14][15][16][17][18] 19 [20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN